NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price, Forecast & Analysis

FRA:NZM2 • DK0060336014

51.24 EUR
-0.5 (-0.97%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership

NZM2.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap21.24B
Revenue(TTM)5.16B
Net Income(TTM)702.70M
Shares414.56M
Float346.28M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.67
Dividend Yield1.67%
EPS(TTM)1.51
PE33.93
Fwd PE25.2
Earnings (Next)02-25
IPO1905-05-27
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
NZM2.DE short term performance overview.The bars show the price performance of NZM2.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6

NZM2.DE long term performance overview.The bars show the price performance of NZM2.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NZM2.DE is 51.24 EUR. In the past month the price decreased by -3.5%.

NOVONESIS (NOVOZYMES) B / NZM2 Daily stock chart

NZM2.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NZM2.DE.


Chartmill TA Rating
Chartmill Setup Rating
NZM2.DE Full Technical Analysis Report

NZM2.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to NZM2.DE. NZM2.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NZM2.DE Full Fundamental Analysis Report

NZM2.DE Financial Highlights

Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.61%
ROA 4.31%
ROE 6.54%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-54.35%
Revenue 1Y (TTM)59.91%
NZM2.DE financials

NZM2.DE Forecast & Estimates

22 analysts have analysed NZM2.DE and the average price target is 64.78 EUR. This implies a price increase of 26.43% is expected in the next year compared to the current price of 51.24.

For the next year, analysts expect an EPS growth of 42.39% and a revenue growth 6.01% for NZM2.DE


Analysts
Analysts73.64
Price Target64.78 (26.42%)
EPS Next Y42.39%
Revenue Next Year6.01%
NZM2.DE Analyst EstimatesNZM2.DE Analyst Ratings

NZM2.DE Ownership

Ownership
Inst Owners38.75%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A
NZM2.DE Ownership

NZM2.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SY1 SYMRISE AG18.710.639B
AKZA AKZO NOBEL N.V.13.8410.352B
AKU1 AKZO NOBEL N.V.13.4110.061B
SYENS SYENSQO SA15.28.399B
EVK EVONIK INDUSTRIES AG13.437.479B
AKE ARKEMA12.74.971B
UMI UMICORE13.624.632B
NVJP UMICORE13.364.605B
WCH WACKER CHEMIE AG121.984.211B
RBT ROBERTET SA17.051.808B

Related stock screener links

View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges

About NZM2.DE

Company Profile

NZM2 logo image Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

Company Info

NOVONESIS (NOVOZYMES) B

Krogshoejvej 36

Bagsvaerd DK

Employees: 10582

NZM2 Company Website

NZM2 Investor Relations

NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ

What does NOVONESIS (NOVOZYMES) B do?

Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..


What is the current price of NZM2 stock?

The current stock price of NZM2.DE is 51.24 EUR. The price decreased by -0.97% in the last trading session.


Does NZM2 stock pay dividends?

NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.67%. The yearly dividend amount is currently 0.67.


How is the ChartMill rating for NOVONESIS (NOVOZYMES) B?

NZM2.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.


Can you provide the upcoming earnings date for NOVONESIS (NOVOZYMES) B?

NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.